These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 7968154

  • 1. Erroneous immunohistochemical application of monoclonal antibody EG2 to detect cellular activation.
    Jahnsen FL, Halstensen TS, Brandtzaeg P.
    Lancet; 1994 Nov 26; 344(8935):1514-5. PubMed ID: 7968154
    [No Abstract] [Full Text] [Related]

  • 2. Monoclonal antibody EG2 reactivity cannot be used as an immunohistochemical activation marker for eosinophils.
    Jahnsen FL, Brandtzaeg P.
    J Leukoc Biol; 1995 Mar 26; 57(3):513-4. PubMed ID: 7884325
    [No Abstract] [Full Text] [Related]

  • 3. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins.
    Nakajima H, Loegering DA, Kita H, Kephart GM, Gleich GJ.
    J Leukoc Biol; 1999 Sep 26; 66(3):447-54. PubMed ID: 10496315
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils.
    Jahnsen FL, Brandtzaeg P, Halstensen TS.
    J Immunol Methods; 1994 Sep 30; 175(1):23-36. PubMed ID: 7930638
    [Abstract] [Full Text] [Related]

  • 5. Relationship of blood EG2+ eosinophils in patients with bronchial asthma.
    Monteseirín J, Llamas E, Muñoz F, Bono MJ, Conde J.
    Allergol Immunopathol (Madr); 1993 Sep 30; 21(3):97-9. PubMed ID: 8356938
    [Abstract] [Full Text] [Related]

  • 6. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma.
    Moqbel R, Barkans J, Bradley BL, Durham SR, Kay AB.
    Clin Exp Allergy; 1992 Feb 30; 22(2):265-73. PubMed ID: 1373987
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemically stained activated eosinophils in sputum in patients with asthma.
    Jang AS, Choi IS, Park CS.
    Respiration; 2000 Feb 30; 67(2):183-8. PubMed ID: 10773791
    [Abstract] [Full Text] [Related]

  • 8. [Eosinophil activation evaluated by using a anti-human secreted form of ECP antibody (EG2)].
    Kobayashi H, Maeda S, Tamura M, Sakamoto S.
    Nihon Rinsho; 1993 Mar 30; 51(3):626-30. PubMed ID: 8492435
    [Abstract] [Full Text] [Related]

  • 9. [The changes of EG1 and EG2 positive eosinophils and their clinical significance in asthmatics].
    Huang H, Xu J, Zhong N.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct 30; 21(10):612-4. PubMed ID: 11477881
    [Abstract] [Full Text] [Related]

  • 10. Immunostaining with monoclonal antibodies to eosinophil cationic protein (EG1 and EG2) does not distinguish between resting and activated eosinophils in formalin-fixed tissue specimens.
    Jahnsen F, Halstensen TS, Brandtzaeg P.
    Adv Exp Med Biol; 1995 Oct 30; 371A():283-6. PubMed ID: 8525926
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of the eosinophil granule proteins recognized by the activation-specific antibody EG2.
    Rosenberg HF, Tiffany HL.
    J Leukoc Biol; 1994 Oct 30; 56(4):502-6. PubMed ID: 7930947
    [Abstract] [Full Text] [Related]

  • 12. The respiratory burst activity of activated eosinophils in atopic asthmatics.
    Tsai JJ, Kao MH, Han SH.
    Int Arch Allergy Immunol; 1999 May 30; 119(1):38-44. PubMed ID: 10341319
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies against eosinophils in liver allograft rejection.
    Ben-Ari Z, Dhillon AP, Moqbel R, Garwood L, Booth D, Rolles K, Davidson B, Burroughs AK.
    Liver Transpl Surg; 1996 Jan 30; 2(1):46-51. PubMed ID: 9346627
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of cytokine RANTES on induction of activated eosinophils].
    Kakazu T, Chihara J, Saito A, Nakajima S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov 30; 33(11):1226-32. PubMed ID: 8583714
    [Abstract] [Full Text] [Related]

  • 16. Whole-blood flow-cytometric analysis of eosinophil EG2 expression as a marker of the pathological conditions of asthma.
    Kuwasaki T, Chihara J, Kayaba H, Kamata Y, Oyamada H, Saito N, Shioya T, Sasaki M, Kagaya M, Tsuda A.
    Int Arch Allergy Immunol; 1998 Sep 30; 117 Suppl 1():77-80. PubMed ID: 9758904
    [Abstract] [Full Text] [Related]

  • 17. Eosinophil activation in Wells' syndrome demonstrated immunohistochemically with antibodies against eosinophilic cationic protein.
    Selvaag E, Roald B.
    Acta Derm Venereol; 2000 Sep 30; 80(1):63-4. PubMed ID: 10721845
    [No Abstract] [Full Text] [Related]

  • 18. Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma.
    Jang AS, Choi IS, Koh YI, Jeong TK, Lee KY, Kim YS, Lee JU, Park CS.
    J Korean Med Sci; 2000 Oct 30; 15(5):521-8. PubMed ID: 11068988
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of patients with mild asthma.
    Fernvik E, Grönneberg R, Lundahl J, Hed J, Andersson O, Johansson SG, Halldén G.
    Allergy; 1996 Oct 30; 51(10):697-705. PubMed ID: 8904997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.